End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
127.4 CNY | +0.25% | -1.43% | -6.98% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company returns high margins, thereby supporting business profitability.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- With an expected P/E ratio at 44.18 and 35.33 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-6.98% | 14.42B | - | ||
-42.66% | 2.62B | C- | ||
-14.27% | 2.42B | - | ||
-16.80% | 1.38B | - | - | |
-.--% | 1.12B | - | - | |
+90.26% | 507M | B+ | ||
+32.34% | 487M | - | ||
+27.01% | 277M | C | ||
+1.88% | 234M | - | - | |
+8.33% | 197M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 688271 Stock
- Ratings Shanghai United Imaging Healthcare Co., Ltd.